Literature DB >> 6984681

Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults.

K Kinoshita, S Hino, T Amagasaki, Y Yamada, S Kamihira, M Ichimaru, T Munehisa, Y Hinuma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984681

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


× No keyword cloud information.
  6 in total

Review 1.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

2.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

3.  Spontaneous remission from acute exacerbation of chronic adult T-cell leukemia.

Authors:  M Murakawa; T Shibuya; T Teshima; J Kudo; T Okamura; M Harada; S Nagafuchi; Y Niho; T Mukae
Journal:  Blut       Date:  1990-12

4.  Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.

Authors:  S Kobayashi; T Yoshida; Y Hiroshige; T Matsui; N Yamamoto
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

5.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

6.  Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).

Authors:  Md Thosif Raza; Shagufta Mizan; Farhana Yasmin; Al-Shahriar Akash; Shah Md Shahik
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.